» Articles » PMID: 36430160

In Silico Discovery of Anticancer Peptides from Sanghuang

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Nov 26
PMID 36430160
Authors
Affiliations
Soon will be listed here.
Abstract

Anticancer peptide (ACP) is a short peptide with less than 50 amino acids that has been discovered in a variety of foods. It has been demonstrated that traditional Chinese medicine or food can help treat cancer in some cases, which suggests that ACP may be one of the therapeutic ingredients. Studies on the anti-cancer properties of have concentrated on polysaccharides, flavonoids, triterpenoids, etc. The function of peptides has not received much attention. The purpose of this study is to use computer mining techniques to search for potential anticancer peptides from 62 proteins of Sanghuang. We used mACPpred to perform sequence scans after theoretical trypsin hydrolysis and discovered nine fragments with an anticancer probability of over 0.60. The study used AlphaFold 2 to perform structural modeling of the first three ACPs discovered, which had blast results from the Cancer PPD database. Using reverse docking technology, we found the target proteins and interacting residues of two ACPs with an unknown mechanism. Reverse docking results predicted the binding modes of the ACPs and their target protein. In addition, we determined the active part of ACPs by quantum chemical calculation. Our study provides a framework for the future discovery of functional peptides from foods. The ACPs discovered have the potential to be used as drugs in oncology clinical treatment after further research.

Citing Articles

Prediction of anticancer peptides derived from the true lectins of and their synergetic effect with mitotane.

Baothman O, Ali E, Hosawi S, Konozy E, Abu Zeid I, Ahmad A Front Pharmacol. 2024; 15:1322865.

PMID: 38464729 PMC: 10920327. DOI: 10.3389/fphar.2024.1322865.

References
1.
Jogl G, Rozovsky S, McDermott A, Tong L . Optimal alignment for enzymatic proton transfer: structure of the Michaelis complex of triosephosphate isomerase at 1.2-A resolution. Proc Natl Acad Sci U S A. 2003; 100(1):50-5. PMC: 140880. DOI: 10.1073/pnas.0233793100. View

2.
Li W, Kamtekar S, Xiong Y, Sarkis G, Grindley N, Steitz T . Structure of a synaptic gammadelta resolvase tetramer covalently linked to two cleaved DNAs. Science. 2005; 309(5738):1210-5. DOI: 10.1126/science.1112064. View

3.
Wu X, Zeng W, Lin F, Xu P, Li X . Anticancer Peptide Prediction Multi-Kernel CNN and Attention Model. Front Genet. 2022; 13:887894. PMC: 9092594. DOI: 10.3389/fgene.2022.887894. View

4.
Siwek W, Czapinska H, Bochtler M, Bujnicki J, Skowronek K . Crystal structure and mechanism of action of the N6-methyladenine-dependent type IIM restriction endonuclease R.DpnI. Nucleic Acids Res. 2012; 40(15):7563-72. PMC: 3424567. DOI: 10.1093/nar/gks428. View

5.
Xu Y, Yang W, Wu J, Shi Y . Solution structure of the first HMG box domain in human upstream binding factor. Biochemistry. 2002; 41(17):5415-20. DOI: 10.1021/bi015977a. View